Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Injection Level in Adductor Canal Block for Total Knee Arthroplasty
NCT07595471Active, not recruiting
- Sponsor
- Ankara Etlik City Hospital
- Start
- Apr 2026
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Ankara Etlik City Hospital. Primary endpoint: Proximal spread of local anesthetic at 1 hour. Started Apr 2026; status: active, not recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07595471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07595471.